tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP

GT Biopharma (GTBP) Financial Statements

213 Followers

GT Biopharma Financial Overview

GT Biopharma's market cap is currently ―. The company's EPS TTM is $-7.041; its P/E ratio is -0.39; GT Biopharma is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 2.27M$ -2.96M$ -1.99M$ 39.00K$ -5.86M
EBITDA$ 2.29M$ -2.96M-$ 64.00K$ -5.84M
Net Income Common Stockholders$ -2.30M$ -2.96M$ -1.99M$ 251.00K$ -5.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.85M$ 13.98M$ 17.97M$ 19.95M$ 16.50M
Total Assets$ 9.91M$ 14.11M$ 18.14M$ 20.13M$ 16.74M
Total Debt$ 30.00K$ 58.00K$ 120.00K$ 147.00K$ 174.00K
Net Debt$ -9.82M$ -13.92M$ -17.85M$ -19.80M$ -16.33M
Total Liabilities$ 4.60M$ 6.63M$ 6.38M$ 7.03M$ 5.00M
Stockholders Equity$ 5.30M$ 7.48M$ 11.76M$ 13.05M$ 11.73M
Cash Flow-
Free Cash Flow$ -4.20M$ -2.05M-$ -2.90M$ -4.30M
Operating Cash Flow$ -4.20M$ -2.05M-$ -2.90M$ -4.30M
Investing Cash Flow$ 5.03M$ 478.00K-$ -6.99M$ 7.51M
Financing Cash Flow---$ 6.27M$ -1.00K
Currency in USD

GT Biopharma Earnings and Revenue History

GT Biopharma Debt to Assets

GT Biopharma Cash Flow

GT Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis